Home    Corporate    Technology   Products   News    FAQ    Job Opportunities    Contact
 
   Food Safety    Environmental Sanitation    Veterinary Applications    Human Therapeutics
 
News & Information
 
News Archive

Food Safety News
March 20, 2013
New Spray Product Takes Aim at Salmonella on Poultry
View the details

Environmental Health Perspectives
February 1, 2013
Phage Renaissance: New Hope against Antibiotic Resistance
View the details

Miller-McCune
April 19, 2012
Defeating Bacteria From the Inside Out
View the details

Bacteriophage
April 1, 2012
The strange history of phage therapy
View the details

The Mark Steiner Show
September 28, 2011
Urbanite Radio Story: Healing Waters
View the details

Urbanite
August 29, 2011
Healing Waters: In the Inner Harbor, the seeds of a medical breakthrough
View the details

Food Safety News
May 9, 2011
Food Pathogen Interventions: Phasing in Phages
View the details

Voice Of America - VOA News.com
March 23, 2011
Killing bacteria with viruses for safer food
View the details

Food Safety News
March 22, 2011
Company Develops Natural Way to Fight E. coli
View the details

Journal of the American Veterinary Medical Association
December 3, 2010
Searching for self-replicating antimicrobials
View the details

Los Angeles Times
September 27, 2010
In The Works:  New Ways to Fight Bacteria
View the details

Gazette.Net Maryland Community Newspapers
October 16, 2009
BioWatch: Baltimore biotech turns to the past for cutting-edge treatment
View the details

PRESS RELEASE - October 7, 2009
Intralytix Wins Army Grant To Develop A Phage-Based Probiotic To Manage Shigella Infections
View the details

PRESS RELEASE - September 11, 2009
Intralytix Receives a Phase I U.S. Army Grant for Phage-Based Product Development

View the details

PRESS RELEASE - June 15, 2009
Intralytix Wins Army Grant for Salmonella and Shigella Technology

View the details

PRESS RELEASE - December 9, 2008
Intralytix awarded patent by USPTO for Bacteriophage treatment of colonization by pathogen bacteria, including MRSA

View the details

PRESS RELEASE - November 26, 2008
Intralytix wins Phase III Army grant for E. Coli technology

View the details

Food Production Daily - July 1, 2008
EPA approved antimicrobial could contol listeria in food plants
By Jane Byrne - A phage-based decontaminant has been sanctioned by the Environmental Protection Agency in the U.S.
View the details

PRESS RELEASE - June 23, 2008
Intralytix Wins EPA Approval of Phage-Based Product, ListShieldTM

View the details

National Public Radio - April 4, 2008
Using 'Phage' Viruses to Help Fight Infection
NPR Talk of the Nation:  Science Friday with Intralytix Vice President, Alexander Sulakvelidze and Author Thomas Hausler.
Listen to audio

New York News - April 23, 2007
Spray to quell E. coli
Baltimore company seeking FDA approval for viral substance to kill the bacteria on produce, raw meat
See entire story

PRESS RELEASE - November 13, 2006
Intralytix Wins Popular Science "Best of What's New" Award
for its food safety product ListShieldTM

View the details

Fox Channel 5 News - November 13, 2006
Morning news segment featuring Intralytix and the FDA approval
of ListShieldTM
View the video

CBS News Video
Spray For Bacteria-Free Meat
Scientists in Baltimore, Maryland are harnessing billions of microscopic organisms in a war against bacteria such as E. coli, listeria and salmonella. Bianca Solorzano has more on phage sprays.
View the video

CNN Video - September 19, 2006
Dr. Sanjay Gupta on the recent FDA approval of ListShield
View the video

The Baltimore Sun
U.S. OKs spray to kill food bacteria
Baltimore firm wins FDA nod for mix of beneficial viruses
See entire story

PRESS RELEASE - August 19, 2006
FDA approves Intralytix’s Food Safety Product (LMP 102)
Baltimore, MD, August 19, 2006:  Intralytix, Inc. announced today that the Food and Drug Administration has approved LMP 102 for use on ready-to-eat food. . .
View the details

Seed Magazine - Feb/Mar, 2006
Trail Phage

Why antibiotics are so 1990's and how their complement may be squelched by the FDA
See entire story

CRC Press - December 28, 2004
Bacteriophages: Biology and Applications
528 page book provides a comprehensive overview of phage history, biology, techniques, and applications. . .
View the Details

Voice of America - VOA News.com, October 27, 2003
"Our World" Broadcast featuring Intralytix

In the never-ending battle against bacterial infection, antibiotics have been the main line of defense since their discovery more than a half-century ago. . .
Listen to Streaming Audio/view text

ASM News, October, 2003
Phage Eyed as Agents To Control Foodborne Pathogens
A bacteriophage and the bacteriocin nisin effectively can control Listeria monocytogenes on contaminated melons and apples . . .
See entire story

Wired Magazine, October, 2003
How Ravenous Soviet Viruses Will Save the World
They're called phages. And they eat drug-resistant bacteria for breakfast.
See entire story

LA Times, March 31, 2003
Enlisting viruses to battle bacteria
As even the most potent antibiotics lose the upper hand against bacteria, researchers are again exploring the potential of bacteriophage . . .
See entire story

Science Magazine, October 25, 2002
Stalin's Forgotten Cure
Bacteriophage therapy, pioneered in Stalin-era Russia, is attracting renewed attention in the West as a potential weapon against drug-resistant bugs and hard-to-treat infections . . .
See entire story

CBS News - 48 Hours, September 20, 2002
Silent Killers: Fantastic Phages?
(CBS) After breaking his foot five years ago, Toronto bass player Alfred Gertler got an infection that antibiotics couldn’t cure. Doctors told him he might have to have his foot amputated . . .
See entire story

Press Release, June 5, 2002
Intralytix Receives First Regulatory Approval
Intralytix, Inc., announced today that it has received regulatory approval from the U.S. Environmental Protection Agency (EPA) . . .
See press release

Washington Techway, January 7, 2002
"Beating Superbugs"
After years of research, phage therapy inches closer to market . . .
See entire strory

Newsweek International, December, 2001
"Superbug Killers"
Western scientists discovered a potent weapon against antibiotic-resistant bacteria in an unlikely place . . .
See entire story

US News & World Report, December, 2001
"Infectious Arms Race"
Forging new weapons against resurgent bacterial killers . . .
See entire story

FoodTech Source, September, 2001
"Phage-Enhanced Food Safety"
See entire story

Agricultural Research Magazine, July, 2001
"Turning the Phage on Produce Pathogens"
Tiny viruses, called phages, infect and kill bacteria naturally . . .
See entire story

Smithsonian Magazine, October, 2000
"The Return of the Phage"
As deadly bacteria increasingly resist antibiotics, researchers try to improve a World War I era weapon . . .
See entire story

National Public Radio, July 21, 2000
"Science Friday" feature discussion on Bacteriophage research with Intralytix founder Dr. Alexander Sulakvelidze
Listen to audio

WKRC, Channel 12 News
Broadcast story on Bacteriophage research featuring Intralytix, Inc.
View the video

McMahonMed, June 20, 2000
"Viruses Called Bacteriophages Resurface As Viable Option To Fight Infections"
See entire story

Science Service, Inc., June 3, 2000
"Viruses That Slay Bacteria Draw New Interest"
See entire story.

Washington Techway, March 13, 2000 "Planning for the day antibiotics fail" (Intralytix Inc's bacteriophage research plans)
See entire story.

New York Times, February 6, 2000
"A Stalinist Antibiotic Alternative"

See entire story.

DoubleTwist, January 21, 2000
"The return of bacteriophage therapies"
See entire story.

 
 
What's New:

Intralytix Wins Regulatory Approval For Phage-Based Food Safety Product Effective Against Salmonella

Intralytix, Inc. announced today that its latest food safety product, SalmoFresh™, has received GRAS (Generally Recognized As Safe) recognition from the Food and Drug Administration (FDA).

Intralytix Signs Multiple Project Collaboration Agreement with Procter & Gamble

Intralytix, Inc. announced today that it has entered into a Multiple Project Collaboration Agreement ("MPCA") with The Procter & Gamble Company (NYSE:PG).

Intralytix Awarded Grant For Managing Salmonella in Food

Intralytix, Inc. announced today that it has been awarded a grant under a National Institute of Food And Agriculture (NIFA) / United States Department of Agriculture (USDA) Small Business Innovative Research (SBIR) Grants Program for the development of a phage preparation for reducing or eliminating Salmonella contamination in foods.

Intralytix Completes Regulatory Clearance for Phage-Based E. coli Food Safety Technology

Intralytix, Inc. announced today that it has completed regulatory clearance from both the Food and Drug Administration (FDA) and the United States Department of Agriculture's Food Safety and Inspection Service (FSIS) for its phage-based EcoShield™ food safety product, effective against E. coli O157:H7.

Intralytix Receives Follow-On Army Contract To Develop A Phage-Based Probiotic To Manage Shigella Infections

Intralytix, Inc. announced today that it has received a U.S. Army Phase II STTR contract supporting the further development of a bacteriophage-based probiotic preparation for managing Shigella infections.

Intralytix's CSO Appointed Editor-In-Chief of New Phage Journal

Intralytix, Inc. announced today that its Chief Scientific Officer, Dr. Alexander Sulakvelidze, has been appointed Editor-In-Chief of a new scientific journal called "Bacteriophage."

Intralytix Receives FDA Regulatory Clearance for Phage-Based E. coli Technology

Intralytix, Inc. announced today that it has received regulatory clearance from the Food and Drug Administration for its phage-based EcoShield™ food safety product, effective against E. coli O157:H7.

Intralytix Wins Army Grant To Develop A Phage-Based Probiotic To Manage Shigella Infections

Intralytix, Inc. announced today that it has received a U.S. Army Phase I STTR grant supporting the development of a bacteriophage-based probiotic preparation for managing Shigella infections.

Intralytix Receives a Phase I U.S. Army Grant for Phage-Based Product Development

Intralytix, Inc. has received a U.S. Army Phase I STTR grant supporting the development of a phage-based product for treating wounds infected with Acinetobacter baumannii.

Intralytix Wins Army Grant

Intralytix has been awarded a contract from the U.S. Army to develop a bacteriophage-based food safety product for reducing or eliminating contamination from pathogenic Salmonella and Shigella spp

Intralytix awarded patent by USPTO

Intralytix has been issued a patent by the U.S. Patent & Trademark Office covering the use of bacteriophages to reduce the risk of bacterial infection in persons colonized with pathogenic bacteria including MRSA

Intralytix, Inc. – ListShield™

Intralytix has received a registration from the Environmental Protection Agency (“EPA”) for ListShield™ as an antimicrobial for use against Listeria monocytogenes.  ListShield is intended for use in food processing plants and food-handing establishments.